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We have established by HPLC age-related reference intervals for sialic acid urinary excretion in 364 control individuals to assist in evaluating the clinical significance of the free sialic acid concentration in urine. In addition, an HPLC method for quantitative analysis of free deoxysialic acid was developed, and age-related reference intervals for excretion of this compound in urine were established. In patients with storage disorders of free sialic acid (n = 11) the sialic acid excretion was increased 2-to 35-fold, compared with the mean value of the control subjects in the corresponding age group, and exceeded the interval in each case. The excretion of deoxysialic acid was within the reference interval in all of the patients, indicating that its metabolism was not affected in the disorders.
The age-related reference values assist in evaluating the excretion of free sialic acid in the diagnosis of storage disorders of free sialic acid, especially in young children. January 18, 1995. amperometric detection (Dionex) (7), gas chromatography (8) , and combined gas chromatography-mass spectrometry (9, 10) . A practical problem in laboratories working on diagnosis of lysosomal disorders is evaluation of whether the excretion of free NANA is actually increased or related to the age and normal physiology of the subject, given that its excretion is higher in young children than in adults (11) . This problem concerns especially Salla disease, in which the excretion of the compound may be only slightly increased. Deoxysialic acid (deoxy-N-acetylneuramiic acid, 2-deoxy-2,3-dehydro-N-acetylneuramiic acid, deoxy-NANA) was found for the first time in nature from a sialuric patient's urine (12) . An increased excretion of the compound in urine has been reported also in one patient with ISSD (13). Since deoxy-NANA is lacking the glycosidic hydroxyl group, it occurs in a free form in biological materials (14) . It has been shown to competitively inhibit the action of neuramiidases (15) (16) (17) .
IIPLC offers a simple and selective method for quantitative analysis of free NANA and other NANA derivatives, and it has been found useful in the diagnosis of sialuria (6) . In this study, TIme, mln A 2-mL aliquot of a 24-h urine sample was passed through AG 50W-X 8(2 mL) and AG 1-X8 (2 mL) columns, and the eluate was collected. Both columns were further eluted twice with either 2 mL of 50 mmoIIL pyridine acetate buffer, pH 5.2, for NANA (6) 
The recovery of 200 moI/L deoxy-NANA in urine after the purification process with 750 mmol/L pyridine acetate as eluate was 96.9% (range 93.7-99.5%, n = 6). The within-day and day-to-day CVs were <4.8% (n = 10) and <5.7% (n = 10), respectively.
Excretion of NANA in urine. The excretion of NANA in urine was determined in 364 controls and the value was correlated to the creatiine content of the corresponding urine specimen (Fig. 3) . From ages 0 to 2 years, the NANA excretion decreased rapidly, from 62.2 ± 52.5 to 34.6 ± 27.0 mol/mmol creatinine (mean ± 1.96 SD). The excretion continued to decrease more slowly until age 10 years, when it was 20.2 ± 11.6 moIJmmol creatiine.
The decrease in excretion continued thereafter more slowly until 27 years of age. From age 27 to 53 years the excretion was almost unchanged, being 11.3 ± 8.9 and 11.8 ± 9.7 mmollmol, respectively.
This downward trend in NANA excretion, tested for an age effect by ANOVA, was statistically highly significant (P <0.0001, F = 57.4). In all of the 10 diagnosed Salla disease patients the excretion of free NANA was above the 95% reference limit. This included the patients younger than 2 years, when the normal variation of excretion is widest (Fig.  3) . The NANA excretion in the Salla disease patients was between 34.2 and 272 mmol/mol creatiine, being 2.4 to 8.1 times the mean values of the control subjects in the corresponding age groups. The concentration of NANA in the urine of the patient with unspecified sialuria (Fig. 1B) was >6 times higher than that in the control urine (Fig. 1C) , but the concentration of deoxy-NANA did not differ from that of the control subject ( Fig. lB and C) . In two samples from one patient with unspecified sialuria, the excretion of free NANA was between 221 and 398 mmollmol creatinine, being 14 to 35 times higher than the mean value of the control subjects in the corresponding age group (Fig. 3) .
Excretion of deoxy-NANA in urine. The excretion of deoxy-NANA was determined in urine samples from 364 normal controls.
A graph of the corresponding reference intervals of excretion of free deoxy-NANA correlated to the creatinine content of the corresponding urine specimen is shown in Fig. 4 . As with NANA, correlating the deoxy-NANA excretion to urinary creatinine content showed less variation in normal controls than did correlating the values to the urine volume (data not shown).
The excretion of deoxy-NANA was within the reference interval in each of the patients with storage disorders of free NANA (Fig. 4) (mean ± 1.96 SD). At age 4 years, the excretion was 17.0 ± 12.0, and at age 10 it was 12.7 ± 7.9 mmollmol creatinine. The excretion of the acid was 9.7 ± 5.5 mmol/mol creatinine at age 27 and 9.0 ± 5.7 at age 53 years. The downward trend in deoxy-NANA excretion, tested for an age effect by ANOVA, was statistically highly significant (P <0.0001, F = 10.0).
Discussion
The diagnosis of storage disorders of free NANA is based on the detection of increased excretion of free NANA in urine (2) . An increased excretion of deoxy-NANA in urine in those disorders has also been reported (13 (19, 20) , which may provide even smoother interval profiles.
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